SCILEX

Pre-clinical

Palo Alto, United StatesFounded 2013scilexholding.com

Scilex Holding Company (Nasdaq: SCLX) is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and becoming the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products that maximize quality of life.

Founded

2013

Focus

Drug Delivery

About

Scilex Holding Company (Nasdaq: SCLX) is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and becoming the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products that maximize quality of life.

Funding History

2

Total raised: $70M

Series B$50MVickers Venture PartnersMar 15, 2023

Series A$20MVickers Venture PartnersJun 15, 2021

Company Info

TypePrivate

Founded2013

LocationPalo Alto, United States

StagePre-clinical

Contact

scilexholding.com

Sectors

Drug Delivery & Formulation Small Molecule Drugs

SIMILAR COMPANIES

BASi Research Products

Pre-clinical · West Lafayette

Bay BioSciences

Pre-clinical · San Francisco

Pre-clinical · Cambridge

Pre-clinical · Memphis

Belcher Pharmaceuticals

Pre-clinical · Miami

Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.